These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19354079)

  • 1. Upper respiratory tract infections and sublingual immunotherapy: preliminary evidence.
    Ciprandi G; Sormani MP; Cirillo I; Tosca M
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):262-3. PubMed ID: 19354079
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose sublingual immunotherapy in children at 8-year follow-up.
    Leonardi S; Spicuzza L; La Rosa M
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):259-60. PubMed ID: 19354077
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunotherapy for allergic rhinitis induced by Japanese cedar pollens].
    Ohashi Y
    Arerugi; 2008 May; 57(5):519-23. PubMed ID: 18520172
    [No Abstract]   [Full Text] [Related]  

  • 4. Anaphylaxis to multiple pollen allergen sublingual immunotherapy.
    Eifan AO; Keles S; Bahceciler NN; Barlan IB
    Allergy; 2007 May; 62(5):567-8. PubMed ID: 17313400
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance and methods of allergen immunotherapy for pollinosis].
    Ohkubo K
    Arerugi; 2008 Feb; 57(2):73-8. PubMed ID: 18349580
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
    Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
    Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Instead of hyposensitization by injection. Dissolving immunotherapy under the tongue?].
    Klein F
    MMW Fortschr Med; 2007 Jan; 149(3):16. PubMed ID: 17632861
    [No Abstract]   [Full Text] [Related]  

  • 8. Anaphylaxis caused by allergen sublingual immunotherapy?
    André C; Fadel R
    Allergy; 2007 Oct; 62(10):1220-1. PubMed ID: 17845597
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of infected allergic rhinitis].
    Dinu IV; Moise O; Lupşea A
    Otorinolaringologie; 1969; 14(1):45-8. PubMed ID: 5768677
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
    Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Kunii N; Yamamoto H; Sakurai D; Hanazawa T
    Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
    Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of short-term immunotherapy using molecular standardized grass and rye allergens compared with symptomatic drug treatment on rhinoconjunctivitis symptoms, skin sensitivity, and specific nasal reactivity.
    Klimek L; Mewes T; Wolf H; Hansen I; Schnitker J; Mann WJ
    Otolaryngol Head Neck Surg; 2005 Oct; 133(4):538-43. PubMed ID: 16213926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis.
    Smith H; White P; Annila I; Poole J; Andre C; Frew A
    J Allergy Clin Immunol; 2004 Oct; 114(4):831-7. PubMed ID: 15480323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of sublingual grass pollen immunotherapy after anaphylaxis.
    Nichani JR; de Carpentier J
    J Laryngol Otol; 2009 Jun; 123(6):683-4. PubMed ID: 18501039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensive and severe oropharyngeal ulcerations under sublingual immunotherapy with a tablet allergenic extract of Phleum pratense.
    Braun JJ; Guenard-Bilbault L; Lipsker D; Chartier A; de Blay F
    Dermatology; 2010; 220(1):51-2. PubMed ID: 19797888
    [No Abstract]   [Full Text] [Related]  

  • 16. Sublingual immunotherapy reduces soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis.
    Ciprandi G; Contini P; Pistorio A; Murdaca G; Puppo F
    Int Immunopharmacol; 2009 Feb; 9(2):253-7. PubMed ID: 19100344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sublingual immunotherapy (SLIT) in the allergologist's practice].
    Mösges R; Köberlein J; Keppler J
    MMW Fortschr Med; 2008 Jun; 150 Suppl 2():79-84. PubMed ID: 18712127
    [No Abstract]   [Full Text] [Related]  

  • 18. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy.
    Pipet A; Botturi K; Pinot D; Vervloet D; Magnan A
    Respir Med; 2009 Jun; 103(6):800-12. PubMed ID: 19216064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis].
    Pfaar O; Hörmann K; Klimek L
    MMW Fortschr Med; 2006 Feb; 148(5):28-32. PubMed ID: 16518935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.